About
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. It offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immuno-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. The company also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, it exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Key Metrics
as of Sep 2026Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 382.00 | 387.00 | 349.00 | 314.00 | 319.00 | 273.00 | 300.00 | 347.00 | 363.00 | 299.00 | 212.00 | 425.00 | 352.00 |
| Expenses | 320.00 | 330.00 | 312.00 | 279.00 | 262.00 | 230.00 | 243.00 | 286.00 | 321.00 | 290.00 | 374.00 | 388.00 | 333.00 |
| Operating Profit | 62.00 | 58.00 | 37.00 | 35.00 | 57.00 | 43.00 | 58.00 | 61.00 | 42.00 | 10.00 | -162.00 | 38.00 | 19.00 |
| OPM % | 16.00 | 15.00 | 11.00 | 11.00 | 18.00 | 16.00 | 19.00 | 18.00 | 12.00 | 3.30 | -76.00 | 9.00 | 5.00 |
| Other Income | 2.00 | 5.00 | -7.00 | 0.00 | 1.00 | 6.00 | 1.00 | 0.00 | 1.00 | -122.00 | -62.00 | -2.00 | 2.00 |
| Depreciation | 27.00 | 26.00 | 26.00 | 24.00 | 24.00 | 24.00 | 25.00 | 25.00 | 25.00 | 25.00 | 26.00 | 26.00 | 26.00 |
| Interest | 20.00 | 27.00 | 22.00 | 21.00 | 24.00 | 29.00 | 27.00 | 28.00 | 31.00 | 31.00 | 25.00 | 24.00 | 26.00 |
| Profit before tax | 17.00 | 10.00 | -17.00 | -10.00 | 11.00 | -5.00 | 8.00 | 8.00 | -12.00 | -168.00 | -275.00 | -15.00 | -30.00 |
| Tax % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | -34.00 |
| Net Profit | 17.00 | 10.00 | -17.00 | -10.00 | 11.00 | -5.00 | 8.00 | 8.00 | -12.00 | -256.00 | -275.00 | -15.00 | -20.00 |
| EPS in Rs | 3.56 | 2.69 | -4.82 | -2.79 | 2.91 | -1.35 | 2.25 | 2.23 | -3.42 | -53.42 | -57.36 | -3.18 | -4.14 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,369.00 | 1,284.00 | 1,289.00 | 1,444.00 | 1,268.00 | 1,617.00 | 1,322.00 | 1,387.00 | 521.00 |
| Expenses | 1,182.00 | 1,080.00 | 1,384.00 | 1,309.00 | 1,187.00 | 1,232.00 | 1,065.00 | 1,173.00 | 462.00 |
| Operating Profit | 187.00 | 204.00 | -95.00 | 134.00 | 81.00 | 385.00 | 257.00 | 214.00 | 59.00 |
| OPM % | 14.00 | 16.00 | -7.00 | 9.00 | 6.00 | 24.00 | 19.00 | 15.00 | 11.00 |
| Other Income | 0.00 | 9.00 | -184.00 | 22.00 | 14.00 | 28.00 | 27.00 | 12.00 | 2.00 |
| Interest | 94.00 | 115.00 | 106.00 | 90.00 | 75.00 | 84.00 | 78.00 | 82.00 | 25.00 |
| Depreciation | 100.00 | 99.00 | 103.00 | 111.00 | 112.00 | 108.00 | 94.00 | 83.00 | 34.00 |
| Profit before tax | -7.00 | -1.00 | -488.00 | -45.00 | -92.00 | 221.00 | 112.00 | 61.00 | 2.00 |
| Tax % | 0.00 | 0.00 | 16.00 | -50.00 | -36.00 | 0.00 | 0.00 | 3.00 | 0.00 |
| Net Profit | -7.00 | -1.00 | -567.00 | -22.00 | -59.00 | 221.00 | 112.00 | 59.00 | 2.00 |
| EPS in Rs | -2.00 | -0.30 | -118.10 | -4.63 | -12.20 | 46.13 | 31.42 | 17.06 | — |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | -49.00 | 0.00 | 11.00 | 5.00 | 22.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 45.00 | 40.00 | 36.00 | 36.00 | 36.00 | 36.00 | 27.00 | 26.00 | 25.00 |
| Reserves | 1,211.00 | 1,056.00 | 901.00 | 1,467.00 | 1,491.00 | 1,557.00 | 1,064.00 | 937.00 | 745.00 |
| Borrowings | 637.00 | 796.00 | 1,012.00 | 1,013.00 | 1,037.00 | 621.00 | 722.00 | 538.00 | 633.00 |
| Other Liabilities | 384.00 | 333.00 | 398.00 | 379.00 | 373.00 | 397.00 | 339.00 | 456.00 | 414.00 |
| Total Liabilities | 2,277.00 | 2,225.00 | 2,347.00 | 2,895.00 | 2,937.00 | 2,610.00 | 2,152.00 | 1,957.00 | 1,817.00 |
| Fixed Assets | 1,231.00 | 1,187.00 | 1,261.00 | 1,342.00 | 1,334.00 | 1,359.00 | 1,374.00 | 1,195.00 | 1,063.00 |
| CWIP | 205.00 | 280.00 | 256.00 | 238.00 | 239.00 | 88.00 | 40.00 | 39.00 | 70.00 |
| Investments | 2.00 | 2.00 | 14.00 | 16.00 | 15.00 | 18.00 | 18.00 | 18.00 | 19.00 |
| Other Assets | 839.00 | 757.00 | 815.00 | 1,298.00 | 1,350.00 | 1,145.00 | 719.00 | 705.00 | 666.00 |
| Total Assets | 2,277.00 | 2,225.00 | 2,347.00 | 2,895.00 | 2,937.00 | 2,610.00 | 2,152.00 | 1,957.00 | 1,817.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 153.00 | 213.00 | 111.00 | 156.00 | -242.00 | 154.00 | 242.00 | 166.00 | 50.00 |
| Cash from Investing Activity | -50.00 | -37.00 | -5.00 | -81.00 | -243.00 | -105.00 | -359.00 | -113.00 | -85.00 |
| Cash from Financing Activity | -103.00 | -180.00 | -107.00 | -113.00 | 334.00 | 92.00 | 97.00 | -23.00 | 67.00 |
| Net Cash Flow | 0.00 | -5.00 | 0.00 | -38.00 | -151.00 | 142.00 | -20.00 | 30.00 | 32.00 |
| Free Cash Flow | 101.00 | 173.00 | 69.00 | 46.00 | -451.00 | -16.00 | -26.00 | 107.00 | 15.00 |
| CFO/OP % | 83.00 | 105.00 | -116.00 | 106.00 | -276.00 | 49.00 | 103.00 | 84.00 | 90.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 117.00 | 93.00 | 99.00 | 136.00 | 141.00 | 109.00 | 63.00 | 76.00 | 185.00 |
| Inventory Days | 170.00 | 185.00 | 163.00 | 258.00 | 321.00 | 149.00 | 170.00 | 111.00 | 252.00 |
| Days Payable | 143.00 | 141.00 | 140.00 | 139.00 | 150.00 | 154.00 | 131.00 | 126.00 | 420.00 |
| Cash Conversion Cycle | 144.00 | 137.00 | 123.00 | 256.00 | 312.00 | 104.00 | 102.00 | 62.00 | 17.00 |
| Working Capital Days | -22.00 | -61.00 | -129.00 | 22.00 | 39.00 | 17.00 | -30.00 | -20.00 | -120.00 |
| ROCE % | 5.00 | 6.00 | -9.00 | 2.00 | -1.00 | 15.00 | 12.00 | 10.00 | — |
Corporate Actions
10 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 17 Sep 2024 | — | — | — | Annual General Meeting |
| Rights | 15 May 2024 | 15 May 2024 | 1:3 | — | |
| Other | 15 May 2024 | 15 May 2024 | — | — | Right Issue of Equity Shares |
| Other | 08 Sep 2023 | — | — | — | Annual General Meeting |
| Other | 12 Aug 2022 | — | — | — | Annual General Meeting |
| Dividend | 18 Aug 2021 | 20 Aug 2021 | — | 3.00 | |
| Dividend | 19 Nov 2020 | 20 Nov 2020 | — | 4.00 | |
| Dividend | 28 Jul 2020 | — | — | 2.00 | |
| Dividend | 06 Aug 2019 | — | — | 5.00 | |
| Other | 18 Sep 2018 | — | — | — | Annual General Meeting |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update22 Jun from crisil
-
Rating update30 Apr from crisil
-
Rating update16 Apr 2025 from crisil
-
Rating update7 Jun 2024 from crisil
-
Rating update3 May 2024 from crisil
-
Rating update22 Feb 2024 from crisil
Conference Calls
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript